BioLineRx's IFRS loss for 2020 was $30.021 million, up 18% from $25.446 million the previous year.
BioLineRx's IFRS loss for 2020 was $30.021 million, up 18% from $25.446 million the previous year.
Financial results
BioLineRx's IFRS loss for 2020 was $30.021 million, up 18% from $25.446 million the previous year. Source: 
ir.biolinerx.com
ir.biolinerx.com
English (US) 